← Open Payments lookup

MICHAEL KASABIAN: Open Payments

NPI 1275527293 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,204 in 56 payments from 20 companies in 2025. Trend: 2023 $1,052 · 2024 $1,410 · 2025 $1,204

Food & beverage: $1,204
CompanyPaymentsAmount
Amgen Inc.6$199
Sumitomo Pharma America, Inc.5$120
Novo Nordisk Inc6$119
Exact Sciences Corporation5$106
PFIZER INC.6$105
Janssen Pharmaceuticals, Inc4$85
Lilly USA, LLC5$83
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$62
GlaxoSmithKline, LLC.2$39

Products named: UPLIZNA, GEMTESA, SPRAVATO, MOUNJARO, The Cologuard Plus Collection Kit, XIFAXAN, EVENITY, Wegovy.

Industry payments across FL — which companies pay providers there.